Contract with Customer, Liability, Current in USD of NovaBridge Biosciences from Q4 2022 to Q4 2023

Taxonomy & unit
us-gaap: CNY and USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
NovaBridge Biosciences quarterly Contract with Customer, Liability, Current history and change rate from Q4 2022 to Q4 2023.
  • NovaBridge Biosciences Contract with Customer, Liability, Current for the quarter ending 31 Dec 2023 was $310,000.000, a 75.4% decline year-over-year.
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Change (%)

NovaBridge Biosciences Quarterly Contract with Customer, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $310,000 -$948,000 -75.4% 31 Dec 2023 20-F 30 Apr 2024
Q4 2022 $1,258,000 31 Dec 2022 20-F 01 May 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.